Yes, We Still Need IL‐2 Receptor Antagonists

Saved in:
Bibliographic Details
Published inAmerican journal of transplantation Vol. 16; no. 11; pp. 3308 - 3309
Main Authors Fleming, J. N., Taber, D. J., Pilch, N. A., Srinivas, T. R., Chavin, K. D.
Format Journal Article
LanguageEnglish
Published United States Elsevier Limited 01.11.2016
Subjects
Antilymphocyte Serum
editorial/personal viewpoint
fusion proteins and monoclonal antibodies: basiliximab/daclizumab
Graft Rejection
Immunosuppressant
immunosuppressive regimens
induction
Interleukin 2
Interleukin 2 receptors
kidney transplantation/nephrology
polyclonal preparations: rabbit antithymocyte globulin
Receptors, Interleukin-2
Immunosuppressant
editorial/personal viewpoint
induction
polyclonal preparations: rabbit antithymocyte globulin
kidney transplantation/nephrology
fusion proteins and monoclonal antibodies: basiliximab/daclizumab
immunosuppressive regimens
Online AccessGet full text

Cover

More Information
Bibliography:SourceType-Other Sources-1
content type line 63
ObjectType-Correspondence-1
ObjectType-Commentary-2
ISSN:1600-6135
1600-6143
DOI:10.1111/ajt.13930